Sign in
BBLGW Stock Price, Chart, Stats & News
Bone Biologics Corporation
Save
Bone Biologics Corporation (BBLGW) does not currently pay a dividend.
935,843
Market cap
–
Current P/E
–
Forward P/E
BBLGW chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -53.64% |
ROE | -59.50% |
D/E | – |
Interest coverage ratio | – |
BBLGW valuation
P/E | – |
P/S | – |
P/B | 0.24x |
P/CF | -0.48x |
P/FCF | -0.74x |
P/OCF | -0.48x |
PEG | 0.07x |
EV multiple | -2.36x |
About
Bone Biologics Corporation is a medical device firm dedicated to revolutionizing bone regeneration, particularly within spinal fusion procedures. The company's primary innovation is NELL-1/DBX, a unique combination product featuring an osteostimulative recombinant protein. This bio-engineered protein offers precise, targeted control over new bone formation.
Similar securities
Based on sector and market capitalization
Report issue